Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension.

Luciana Neves Cosenso-MartinLais Yumi TakaokaJosé Fernando Vilela-Martin

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

Vildagliptin reduces GV; however, the action on endothelial function was not demonstrated. In addition, there was no correlation between GV and endothelial function.

Keyphrases

blood pressure
blood glucose
type diabetes
metabolic syndrome
insulin resistance